Sofinnova Investments, Inc.
SEC-registered investment adviser.
- Website
- HTTP://WWW.SOFINNOVA.COM/
- HQ
- CA
Sofinnova Investments, Inc. is a healthcare investment firm focused on life science investing, mainly therapeutics. It invests in late preclinical and clinical therapeutic companies across the U.S. and Europe. Its team includes Managing Partner Jim Healy, MD, PhD, and its portfolio includes Claris Bio, City Therapeutics, and Expedition Therapeutics.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series B, Series A |
| Sectors | Biotech | Not enough dated deals | Biotech, Healthtech, Medical devices, Hardware |
| Regions | Global | Not enough dated deals | CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 1998 | 1 | Biotech, Healthtech |
| 1999 | 3 | AI applications, Hardware, Media |
| 2000 | 9 | Devtools, Cybersecurity, Enterprise SaaS |
| 2001 | 7 | Data analytics, Media, Biotech |
| 2002 | 10 | Biotech, Healthtech, Consumer |
| 2003 | 11 | Biotech, Healthtech, Hardware |
| 2004 | 18 | Biotech, Healthtech, Cybersecurity |
| 2005 | 6 | Biotech, Healthtech, Cybersecurity |
| 2006 | 8 | Biotech, Enterprise SaaS, Hardware |
| 2007 | 21 | Biotech, Healthtech, Media |
| 2008 | 8 | Biotech, Healthtech, Hardware |
| 2009 | 8 | Biotech, Healthtech, Medical devices |
| 2010 | 12 | Biotech, Healthtech, Media |
| 2011 | 7 | Biotech, Healthtech, Medical devices |
| 2012 | 13 | Biotech, Healthtech, Enterprise SaaS |
| 2013 | 13 | Biotech, Healthtech, Medical devices |
| 2014 | 16 | Biotech, Healthtech, Life sciences and research tools |
| 2015 | 15 | Biotech, Healthtech, Medical devices |
| 2016 | 3 | Biotech, Healthtech, Life sciences and research tools |
| 2017 | 13 | Biotech, Healthtech, Devtools |
| 2018 | 10 | Biotech, Healthtech, Devtools |
| 2019 | 5 | Biotech, Healthtech |
| 2020 | 6 | Biotech, Healthtech, Medical devices |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 0 | 2 | 2 | 5 |
| 2011 | 0 | 0 | 0 | 4 | 1 |
| 2012 | 0 | 0 | 1 | 1 | 4 |
| 2013 | 0 | 0 | 4 | 0 | 6 |
| 2014 | 0 | 0 | 1 | 6 | 7 |
| 2015 | 0 | 0 | 2 | 2 | 10 |
| 2016 | 0 | 0 | 2 | 1 | 0 |
| 2017 | 0 | 0 | 2 | 6 | 4 |
| 2018 | 0 | 0 | 4 | 3 | 2 |
| 2019 | 0 | 0 | 3 | 1 | 0 |
| 2020 | 0 | 0 | 0 | 3 | 3 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Sofinnova Venture Partners XII, L.P. Sofinnova is a healthcare investment firm focused on life science investing, primarily therapeutics. It invests in late preclinical and clinical therapeutic companies across the U.S. and Europe, with key areas including oncology, respiratory, dermatology, ophthalmology, neurology and women's health. Inferred from the firm's website | 2024 | $527.07M to $550M (Form D) | Raising |
| Sofinnova Venture Partners XI, L.P. | 2021 | $500M (Form D) | Follow-ons only |
03 · People across funds
- James Healy, Managing Member of the GP of the GP
Sofinnova Venture Partners XII, L.P. (Named on Form D); Sofinnova Venture Partners XI, L.P. (Named on Form D)
- Maha Katabi, General Partner
Sofinnova Venture Partners XII, L.P. (Named on Form D); Sofinnova Venture Partners XI, L.P. (Named on Form D)
- Eric Delbridge, MD, General Partner, Public Equity
Sofinnova Venture Partners XII, L.P. (Team); Sofinnova Venture Partners XI, L.P. (Team)
- Jim Healy, MD, PhD, Managing Partner
Sofinnova Venture Partners XII, L.P. (Team); Sofinnova Venture Partners XI, L.P. (Team)
- Jonathan Leff, MD, Executive Partner, Private Equity
Sofinnova Venture Partners XII, L.P. (Team); Sofinnova Venture Partners XI, L.P. (Team)
- Maha Katabi, PhD, CFA, General Partner
Sofinnova Venture Partners XII, L.P. (Team); Sofinnova Venture Partners XI, L.P. (Team)
- Mike Van, PhD, Associate, Private Equity
Sofinnova Venture Partners XII, L.P. (Team); Sofinnova Venture Partners XI, L.P. (Team)
- Chris Carpenter, Executive Partner, Private Equity
On the team page, not linked to a fund
- Eric Delbridge, General Partner, Public Equity
On the team page, not linked to a fund
- Jakob Dupont, Executive Partner, Private Equity
On the team page, not linked to a fund
- Jim Healy, Managing Partner
On the team page, not linked to a fund
- Jonathan Leff, Executive Partner, Private Equity
On the team page, not linked to a fund
- Maha Radhakrishnan, Executive Partner, Private Equity
On the team page, not linked to a fund
- Nathalie Auber, Partner & CFO
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.SOFINNOVA.COM/
- https://www.sofinnova.com/contact/
- https://www.sofinnova.com/people/
- https://www.sofinnova.com/portfolio/
- https://www.sofinnova.com/about/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026